399 related articles for article (PubMed ID: 32670438)
1. Selected Metal Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases as Potential Biomarkers for Tubulointerstitial Fibrosis in Children with Unilateral Hydronephrosis.
Bieniaś B; Sikora P
Dis Markers; 2020; 2020():9520309. PubMed ID: 32670438
[TBL] [Abstract][Full Text] [Related]
2. [Serum and urinary concentration of selected metalloproteinases and their tissue inhibitors in children with vesicoureteral reflux].
Taranta-Janusz K; Zoch-Zwierz W; Wasilewska A; Tenderenda E; Korzeniecka-Kozerska A
Pol Merkur Lekarski; 2010 Aug; 29(170):88-92. PubMed ID: 20842819
[TBL] [Abstract][Full Text] [Related]
3. Urinary metalloproteinases and tissue inhibitors of metalloproteinases as potential early biomarkers for renal fibrosis in children with nephrotic syndrome.
Bieniaś B; Sikora P
Medicine (Baltimore); 2018 Feb; 97(8):e9964. PubMed ID: 29465592
[TBL] [Abstract][Full Text] [Related]
4. Potential Novel Biomarkers of Obstructive Nephropathy in Children with Hydronephrosis.
Bieniaś B; Sikora P
Dis Markers; 2018; 2018():1015726. PubMed ID: 30327688
[TBL] [Abstract][Full Text] [Related]
5. Urinary extracellular matrix proteins as predictors of the severity of ureteropelvic junction obstruction in children.
Mello MF; Thalita Dos Reis S; Kondo EY; de Bessa Júnior J; Dénes FT; Lopes RI
J Pediatr Urol; 2021 Aug; 17(4):438.e1-438.e7. PubMed ID: 33863647
[TBL] [Abstract][Full Text] [Related]
6. Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid.
Leroy V; Monier F; Bottari S; Trocme C; Sturm N; Hilleret MN; Morel F; Zarski JP
Am J Gastroenterol; 2004 Feb; 99(2):271-9. PubMed ID: 15046217
[TBL] [Abstract][Full Text] [Related]
7. Urinary Emmprin, matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 as potential biomarkers in children with ureteropelvic junction narrowing on conservative treatment.
Tian F; Gu C; Zhao Z; Li L; Lu S; Li Z
Nephrology (Carlton); 2015 Mar; 20(3):194-200. PubMed ID: 25470073
[TBL] [Abstract][Full Text] [Related]
8. Association between urinary biomarkers MMP-7/TIMP-2 and reduced renal function in children with ureteropelvic junction obstruction.
Wang HS; Cho PS; Zhi H; Kostel SA; DiMartino S; Dagher AM; Davis KH; Cabour LD; Shimmel A; Lee J; Froehlich JW; Zurakowski D; Moses MA; Lee RS
PLoS One; 2022; 17(7):e0270018. PubMed ID: 35834547
[TBL] [Abstract][Full Text] [Related]
9. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
10. Imbalance of metallaproteinase/tissue inhibitors of metalloproteinase system in renal transplant recipients with chronic allograft injury.
Mazanowska O; Kamińska D; Krajewska M; Zabińska M; Kopeć W; Boratyńska M; Chudoba P; Patrzalek D; Klinger M
Transplant Proc; 2011 Oct; 43(8):3000-3. PubMed ID: 21996210
[TBL] [Abstract][Full Text] [Related]
11. Urine Levels of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Children with Type 1 Diabetes Mellitus.
Yürük Yıldırım Z; Yılmaz A; Pehlivanoğlu C; Gedikbaşı A; Yıldız M; Dirican A; Bundak R; Darendeliler F; Emre S; Nayır A
J Clin Res Pediatr Endocrinol; 2019 May; 11(2):157-163. PubMed ID: 30396876
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases (MMP-2,9) and their tissue inhibitors (TIMP-1,2) as novel markers of stress response and atherogenesis in children with chronic kidney disease (CKD) on conservative treatment.
Musiał K; Zwolińska D
Cell Stress Chaperones; 2011 Jan; 16(1):97-103. PubMed ID: 20821177
[TBL] [Abstract][Full Text] [Related]
13. Urinary MMP-9/NGAL ratio as a potential marker of FSGS in nephrotic children.
Korzeniecka-Kozerska A; Wasilewska A; Tenderenda E; Sulik A; Cybulski K
Dis Markers; 2013; 34(5):357-62. PubMed ID: 23478276
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H
Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease.
Navratilova Z; Zatloukal J; Kriegova E; Kolek V; Petrek M
Respirology; 2012 Aug; 17(6):1006-12. PubMed ID: 22591289
[TBL] [Abstract][Full Text] [Related]
16. [Age-related dynamics of the contents of matrix metalloproteinases (MMP-1, -2, -3, -9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, -2, -4) in blood plasma of residents of the European part of the Arctic zone of the Russian Federation.].
Kim LB; Russkih GS; Putyatina AN; Tsypysheva OB
Adv Gerontol; 2018; 31(2):223-230. PubMed ID: 30080329
[TBL] [Abstract][Full Text] [Related]
17. [Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in the urine of children with pyelonephritis].
Tenderenda E; Zoch-Zwierz W; Wasilewska A; Porowski T; Taranta-Janusz K; Kołodziejczyk Z; Michaluk-Skutnik J
Pol Merkur Lekarski; 2009 Jul; 27(157):10-3. PubMed ID: 19650421
[TBL] [Abstract][Full Text] [Related]
18. Urinary Metalloproteinases-9 and -2 and Their Inhibitors TIMP-1 and TIMP-2 are Markers of Early and Long-Term Graft Function After Renal Transplantation.
Kwiatkowska E; Domanski L; Bober J; Safranow K; Romanowski M; Pawlik A; Kwiatkowski S; Ciechanowski K
Kidney Blood Press Res; 2016; 41(3):288-97. PubMed ID: 27160811
[TBL] [Abstract][Full Text] [Related]
19. Evaluating TIMP-2 and IGFBP-7 as a predictive tool for kidney injury in ureteropelvic junction obstruction.
Mello MF; de Bessa J; Reis ST; Kondo EY; Yu L; Dénes FT; Lopes RI
Int Braz J Urol; 2022; 48(2):284-293. PubMed ID: 35170890
[TBL] [Abstract][Full Text] [Related]
20. The association of vascular endothelial growth factor, metalloproteinases and their tissue inhibitors with cardiovascular risk factors in the metabolic syndrome.
Erman H; Gelisgen R; Cengiz M; Tabak O; Erdenen F; Uzun H
Eur Rev Med Pharmacol Sci; 2016; 20(6):1015-22. PubMed ID: 27049251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
